"Adaptive Immunity" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Protection from an infectious disease agent that is mediated by B- and T- LYMPHOCYTES following exposure to specific antigen, and characterized by IMMUNOLOGIC MEMORY. It can result from either previous infection with that agent or vaccination (IMMUNITY, ACTIVE), or transfer of antibody or lymphocytes from an immune donor (IMMUNIZATION, PASSIVE).
| Descriptor ID |
D056704
|
| MeSH Number(s) |
G12.450.050
|
| Concept/Terms |
Adaptive Immunity- Adaptive Immunity
- Adoptive Immunity
- Immunity, Adoptive
- Immunity, Adaptive
- Acquired Immunity
- Immunity, Acquired
|
Below are MeSH descriptors whose meaning is more general than "Adaptive Immunity".
Below are MeSH descriptors whose meaning is more specific than "Adaptive Immunity".
This graph shows the total number of publications written about "Adaptive Immunity" by people in this website by year, and whether "Adaptive Immunity" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 2 | 3 | 5 |
| 2011 | 1 | 2 | 3 |
| 2012 | 1 | 4 | 5 |
| 2013 | 0 | 1 | 1 |
| 2014 | 1 | 1 | 2 |
| 2015 | 6 | 1 | 7 |
| 2016 | 3 | 3 | 6 |
| 2017 | 2 | 4 | 6 |
| 2018 | 2 | 0 | 2 |
| 2019 | 4 | 7 | 11 |
| 2020 | 0 | 2 | 2 |
| 2021 | 2 | 4 | 6 |
| 2022 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 1 |
| 2024 | 1 | 2 | 3 |
| 2025 | 1 | 1 | 2 |
| 2026 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Adaptive Immunity" by people in Profiles.
-
Anti-CSF-1R therapy with combined immuno-chemotherapy coordinate an adaptive immune response to eliminate macrophage enriched triple negative breast cancers. Nat Commun. 2026 Jan 03; 17(1):1193.
-
Sugar Functionalized Collagen Material for Local Modulation of Innate Immunity. Adv Sci (Weinh). 2025 Aug; 12(31):e2415364.
-
Sigma1 inhibitor suppression of adaptive immune resistance mechanisms mediated by cancer cell derived extracellular vesicles. Cancer Biol Ther. 2025 Dec; 26(1):2455722.
-
Studying bats using a One Health lens: bridging the gap between bat virology and disease ecology. J Virol. 2024 12 17; 98(12):e0145324.
-
The zebrafish as a potential model for vaccine and adjuvant development. Expert Rev Vaccines. 2024 Jan-Dec; 23(1):535-545.
-
Durable lymph-node expansion is associated with the efficacy of therapeutic vaccination. Nat Biomed Eng. 2024 10; 8(10):1226-1242.
-
An ocular Th1 immune response promotes corneal nerve damage independently of the development of corneal epitheliopathy. J Neuroinflammation. 2023 May 22; 20(1):120.
-
Contribution of adaptive immunity to human COPD and experimental models of emphysema. Physiol Rev. 2023 04 01; 103(2):1059-1093.
-
Deep dissection of the antiviral immune profile of patients with COVID-19. Commun Biol. 2021 12 16; 4(1):1389.
-
A Modular Biomaterial Scaffold-Based Vaccine Elicits Durable Adaptive Immunity to Subunit SARS-CoV-2 Antigens. Adv Healthc Mater. 2021 11; 10(22):e2101370.